Kidney transplantation outcomes from expanded criteria donors, standard criteria donors or living donors older than 60 years

Ren Fail. 2014 May;36(4):526-33. doi: 10.3109/0886022X.2013.876348. Epub 2014 Jan 23.

Abstract

Objectives: To evaluate outcomes in kidney allograft recipients from donors with expanded criteria (ECD) versus standard criteria (SCD) or living donors (LD) >60 years.

Methods: We studied all patients who received a kidney between 2005 and 2011, focusing in recipients of kidneys from deceased ECD, SCD and LD >60 years. ECD was any deceased donor >60 years or >50 years with two of the following: hypertension (HTN), stroke as the cause of death, or serum creatinine >1.5 mg/dL. We recorded characteristics of the transplant procedure, patient, graft survival and renal function 1 year after transplantation and at the end of follow-up.

Results: Six-hundred and five patients were transplanted between 2005 and 2011 in our department. There were 142 (25.1%) transplantations from ECD, 192 (33.98%) from SCD and 96 (16.99%) from LDs older than 60 years. In a mean follow-up time of 36.4 months, graft survival rates were similar for all groups. Calculated GFR was found statistically different between the ECD and SCD groups, but still satisfactory at first year, and at end of follow-up time. Comparison of the patients, who received transplants from ECD, even older than 70 years, and those from LD >60 years revealed equivalent renal function in short and long term.

Conclusions: Utilization of marginal kidneys effectively doubled our deceased transplant volume in the period 2005-2011. Patients' and graft survival were shown similar at the end of follow-up for all groups. Renal outcomes were shown equivalent between the ECD and LD >60 years groups, and although significantly lower between the ECD and the SCD group, were still very satisfactory.

MeSH terms

  • Age Factors
  • Allografts
  • Donor Selection / standards*
  • Glomerular Filtration Rate
  • Graft Survival*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation*
  • Living Donors
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome

Substances

  • Immunosuppressive Agents